Welcome To Asia Research Partners LLP

Client Login

+91 011 4105 2539



Asia Research Partners focuses on Pharmaceutical, Healthcare and advisory research services, bringing clarity to the market forces, trends, and impacts of physician and consumer use of information technology.

Asia Research partners provides primary market research services to pharmaceutical, biotech, medical device, diagnostics and global medical research firms. Offering a full range of qualitative and quantitative research services, the company custom-designs each study to address specific client and project objectives. Asia Research Partners has a solid reputation for providing actionable information for its clients, and it is one of the most trusted and fastest growing research suppliers in the healthcare industry. The firm's deliverables are recognized not only for their data collection, analytical and reporting rigor but also for the presentation-ready formats in which they are provided.

Our intervention bears the whole scope of Medical and HealthCare actors

General Practitioners Radiologists Hospital based practitioners
Private Practice Specialists Nuclear Medicine doctors Hospital Pharmacists
Nurses Cardiologists Surgeons
Dieticians Oncologists Ophthalmologists
Dentists Pharmacists Gastroenterologists
The universes of therapeutics in which we are intervening the most frequently are :

Antibiotherapy Anti-hyper cholesterolemia
Gynecology Diagnostics
Immunology Asthma
Diabetes Anti-inflammatory, pain killers
Radiology Dermatology
Oncology Ophthalmology
Neurology: Multiple Sclerosis

India Healthcare Sector

The Indian healthcare industry is seen to be growing at a rapid pace and is expected to become a US$280 billion industry by 2020. The Indian healthcare market was estimated at US$35 billion in 2007 and is expected to reach over US$70 billion by 2012 and US$145 billion by 2017. According to the Investment Commission of India the healthcare sector has experienced phenomenal growth of 12 percent per annum in the last 4 years.
Rising income levels and a growing elderly population are all factors that are driving this growth. In addition, changing demographics, disease profiles and the shift from chronic to lifestyle diseases in the country has led to increased spending on healthcare delivery.

"Healthcare has emerged as one of the most progressive and largest service sectors in India with an expected GDP spend of 8 per cent by 2012 from 5.5 per cent in 2009. It is believed to be the next big thing after IT and as mentioned above to become a US$ 280 billion industry by 2020.

India spending in healthcare as a % of GPD is 5.2%.

As per a study by an industry body and Ernst & Young, India would require another 1.75 million beds by the end of 2025. The public sector however is likely to contribute only around 15-20 per cent of the required US$ 86 billion investment.

The size of the Indian medical technology industry may touch US$ 14 billion by 2020 from US$ 2.7 billion in 2008 on account of strong economic growth, higher public spending and private investments in healthcare, increased penetration of health insurance and emergence of new models of healthcare delivery, according to a report 'Medical Technology in India

The public and private health insurance sectors in India have witnessed strong growth in recent years and are expected to experience continued, if not accelerated, growth in the near future. In the years 2002-2007, health insurance premiums increased five-fold from INR 6.75 B to INR 33 B (approximately $800 M). The market is currently expected to reach INR 200 B (approximately $4.4 B) within the next five years. Without a doubt, the health insurance sector in India is experiencing rapid changes and presents opportunities for more private insurers to enter the market.

India has approximately 600,000 allopathic doctors registered to practice medicine. This number however, is higher than the actual number practicing because it includes doctors who have emigrated to other countries as well as doctors who have died.

Economic indicators
GDP (in $ billion, 2004) 674.8
Per Capita (in $, 2004) 603
  • Real Growth (in %, 2004) 6.4
  • Health expenditure (in $ billion, 2003) 29.3
  • Health expenditure as % of GDP 5.1
  • Public expenditure as % total 20